Charity Navigator, the nation’s largest independent rater of non-profits, just upgraded the IWMF to a 4-star rating. Learn the surprising reason why we were upgraded.
Deborah Barksdale’s WM led to some frightening medical challenges. But by staying positive, and with support from loved ones, she sustains a full and rewarding lifestyle.
The critical IWMF-LLS Strategic Research Roadmap partnership is extended through 2020.
The IWMF is excited to announce the newly redesigned Stories of Hope website page!
Emil Parente, 88 years old, is a WMer with a real past, and he is happy to share it with others, particularly those who are newly diagnosed.
The IWMF Board of Trustees announces funding for two new IWMF-LLS Strategic Research Roadmap projects and for ongoing research by Dr. Steven Treon and Dr. Stephen Ansell.
Registration is still available to attend the October 13-14 International Patient Conference on WM, and to hear presentations from leading worldwide researchers
The IWMF is invited to participate in the LLS’s new effort to collect data from electronic medical records for patients seen in the US. In just a few steps, your data can be on its way!
The IWMF is pleased to announce that the U.S. FDA has approved the combination treatment of Imbruvica (ibrutinib) together with Rituximab (rituxan) for the treatment of WM.
Tom Hoffmann, MD, is the newest member of the Board of Trustees. His medical background and knowledge of WM will be of great benefit to the IWMF community.